Особенности клинического течения и коагуляционно-тромбоцитарного гемостаза у больных с метаболическим синдромом и внебольничной пневмонией
Диссертация
У’больных с метаболическим синдромом и внебольничной пневмонией дополнительными критериями степени тяжести могут служить показатели уровня СРБ-hs, Д-димеров, спонтанной и АДФ-индуцированной агрегации тромбоцитов в период разгара внебольничной пневмонии и в период разрешения. У больных с метаболическим синдромом с целью определения уровня системного воспаления и нарушений… Читать ещё >
Список литературы
- Акмаев И.Г. Нейроиммуноэндокринные аспекты патогенеза сахарного диабета/ Сахарный диабет 2005- 3: 8−12.
- Акмаев И.Г. Проблемы и перспективы развития нейроиммуноэндокринологии. Проблемы эндокринологии 1999- 5: с. 38.
- Аметов А.С., Демидова Т. Ю., Целиковская A.J1. Влияние лептина на ругуляцию массы тела. Сердечная недостаточность 2001- 3: 135−137.
- Аметов А.С., Демидова Т. Ю., Целиковская A.JI. Комплексная оценка метаболических показателей у больных с ожирением на фоне лечения ксеникалом. Терапевтический архив. — 2004. № 1. — С. 49−53.
- Ардаматский Н. А., Абакумова Ю. В. Показатели инфекционного процесса при атеросклерозе. Рос. кардиол. журн. 1998- 6: 3−9.
- Аронов Д.М. Плеотропные эффекты статинов. Русский медицинский журнал. 2003. — № 9. — С. 13−14.
- Балаболкин М.И. Диабетология. М., 2000, 430с.
- Баранова Е.И., Большакова О. О. Метаболический сердечно-сосудистый синдром в постменопаузе. Обзоры клинической кардиологии. 2005. -№ 1.-С. 2−12.
- Беленков Ю.Н., Мареев В. Ю. Сердечно-сосудистый континуум.// Сердечная недостаточность. — 2002. Том 3, № 1.-С. 3−8.
- Беляков Н.А., Сеидова Г. Б., Чубриева С. Ю., Глухов Н. В. Метаболический синдром у женщин. СПб. 2005- 440 с.
- Богомолов Б.П., Малькова Т. Н., Девяткин А. В. Острые респираторные заболевания и сердце. М.: Фонд им. И. Д. Сытина, 2003. ч
- Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. Русский медицинский журнал 2000- 9: 56−60.
- Бутрова С. А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. Русский медицинский журнал 2001- 9: с. 56−60.
- Бутрова С.А., Дзогоева Ф. Х. Висцеральное ожирение ключевое звено метаболического синдрома. Ожирение и метаболизм 2004- 1: 1016. ч
- Гинзбург М.М., Козупица Г. С. Синдром инсулинорезистентности. Проблемы эндокринологии. — 1997. № 1. — с. 40−43.
- Гинзбург М.М., Козупица Г. С. Синдром инсулинорезистентности. Проблемы эндокринологии. — 1997. № 1. — С.40−43.
- Грацианский Н.А. Нестабильная стенокардия — острый коронарный синдром. III. Предупреждение обострений ишемической болезни сердца. Кардиология 1997:11:4—17.
- Григорян О.Р., Анциферов М. Б. Современные аспекты патогенеза инсулинорезистентности при синдроме поликистозных яичников и возможности ее коррекции у женщин с избыточной массой тела. Проблемы репродукции. 2000. — № 3. — с. 12−16.
- Гуревич В. С., Плесков В. М., Уразгильдеева С. А. и др. Роль вирусов гриппа в прогрессировании атеросклероза. В кн.:ч
- Всероссийская науч. конф. «Кардиология — XXI век»: Материалы конф. СПб.- 2001: 212−213.
- Данные Федерального государственного наблюдения, форма № 2 «Сведения об инфекционных и паразитарных заболеваниях». ч
- Дворецкий Л.И. Пожилой больной и инфекция. Инфекции и антимикробная терапия. 2002. — № 6. — с. 15−18.
- Девяткин А.В. Состояние микроциркуляции и гемостаза при гриппе и острых респираторных вирусных инфекциях у больных, отгощенных ишемической ьолезнью сердца. Автореф. Дис.канд. Мед. Наук. М., 1990.-25с.
- Дильман В.М. Большие биологические часы часы. М. 1982. 125с
- Дмитриев А.Н. Ожирение и метаболический синдром. Екатеринбург. 2001.-160 с.
- Задионченко В. С, Адашева Т. В., Демичева О. Ю., Порывкина О. Н. Метаболический синдром: терапевтические возможности и перспективы. Consilium medicum 2005. — № 9. — С. 725−733.
- Задионченко B.C., Адашева Т. В., Демичева О. Ю., Порывкина О. Н. Метаболический синдром: лечение ожирения и нарушений углеводного обмена. Справочник поликлинического врача 2005- 5:3−7.
- Зимин Ю. В. Происхождение, диагностическая концепция и клиническое значение синдрома инсулинорезистентности или метаболического синдрома X. Кардиология. 1998- 6:71−81.
- Извозчикова Н.В. Состояние гемостаза и микроциркуляции при гриппе-- и острых респираторных вирусных инфекциях у больных сахарным диабетом: Автореф. Дис. .канд. Мед. Наук. М., 1995. — 30с.
- Карпов Ю.А., Сорокин Е. В., Фомичева О. А. Воспаление и атеросклероз: состояние проблемы и нерешенные вопросы. Сердце 2003- 1.2, 4(10): 190−192.
- Климов А.Н., Никульчева Н. Г. Обмен липидов и липопротеидов и его нарушения. СПб: Питер Ком, 1999. — 512 с.
- Кобалава Ж.Д., Толкачева В. В. Метаболический синдром: принципы лечения. Русский медицинский журнал. 2005. — т. 13, № 7. — С. 451 458. '
- Козлов B.C., Шиленкова В. В., Чистякова О. Д. Роль воспаления в патогенезе респираторных заболеваний. Consilium medicum. 2003. -Т.5, N 10. — С. 566−573.
- Котовская Ю.В. Метаболический синдром: прогностическое значение и современные подходы к комплексной терапии. Сердце 2005- Т. 4,5 (23): 236−242.
- Кравец Е.Б. Клинические лекции по детской эндокринологии. Томск ИД «Тандем-Арт». 2004. — 363 с.
- Лебедев К.А., Понякина И. Д. Иммунная недостаточность, выявление и лечение. М. Медицинская книга. 2003, 443с.
- Лобзин Ю. В., Васильев В. В. Приобретенный токсоплазмоз: критерии диагностики и принципы лечения. Рос. мед. журн. 2001- 2: 4345.
- Лобзин Ю.В., Лихопроенко В. П., Львов Н. И. Воздушно-капельные инфекции. — СПб: Фолиант, 2000. 184с.
- Лобзин Ю.В., Рудакова А. В. Роль инфекционно-воспалительного фактора в развитии атеросклероза // Мед. академический журнал. — 2003. Т. 3, № 2. — С. 80−89
- Лысикова М., Вальд М., Масиновски 3. Механизмы воспалительной реакции и воздействие на них с помощью протеолитических энзимов. Цитокины и воспаление 2004- т. З, 3: С. 48−53.
- Малеев В.В., Покровский В. И. Инфекционные болезни в России: проблемы и пути их решения // Терапевтический архив. 2004. — № 4. -С. 5−9.^
- Автореф. дис. канд. мед. наук. СПб., 2004.
- Матвеева JI.A., Кондратьева Е. И. Динамика клинико-иммунологических показателей при реабилитации детей с ожирением. Педиатрия. -1994. № 3. — С. 101.
- Мельниченко Г. А. Ожирение в практике эндокринолога. Русский медицинский журнал. — 2001. № 2. — с. 82−87.
- Мельниченко Г. А., Глинкина И. В. Статины в лечении дислипидемии при сахарном диабете 2 типа. Ожирение и метаболизм. 2005. № 1. — С. 21−26. -
- Мкртумян A.M. Особенности течения и лечения нарушений углеводного обмена при метаболическом синдроме. Сердце 2005- Т.4, 5: 273−276.
- Мыч*са В.Б., Чазова И. Е. Сахарный диабет 2 типа и артериальная гипертензия. Сердце. —2004. № 1. — с.13−16.
- Нагорнев В.А., Мальцева С. В. Роль инфекции в развитии иммунного воспаления и патогенезе атеросклероза. // Архив патологии. 2000. — Т.62, N° 6. — С. 55−59.
- Никитин Ю.П., Казека Г. Р., Симонова Г. И. Распространенность компонентов метаболического синдрома в неорганизованной городской популяции (эпидемиологическое исследование). Кардиология 2001- 9: 37−40.
- Никитин Ю.П., Решетников О. В., Курилович С. А., Малютина С.К, Кривенчук Н. А., Еремеева Л. И., Хрянин А. А. Ишемическая болезнь сердца, хламидийная и хеликобактерная инфекции (популяционное исследование) // Кардиология. 2000. — № 8. — С. 4−7.
- Ожирение, руководство для врачей. Под редакцией И. И. Дедова, Г. А. Мельниченко. МИА, Москва, 2004, 450 с.
- Олифиренко Г. А., Чиликина Г. В., Шевченко О. П. С-реактивный белок в современной лабораторной практике. — Лаборатория. — 1999. -№ 4. С. 8−9.
- Онищенко Г. Г. Контроль и ликвидация инфекционных заболеваний стратегическое направление здравоохранения // Журнал микробиология, эпидемиология и иммунобиология. — 2002. — № 4. С. 3,10.
- Пампу С. Ю., Быстрсвская В. Б., Смирнов В. Н. и др. Сверхранний антиген цитомегаловируса в клетках различных слоев аорты человека. Кардиология 2000- 40 (7): 27−35. 5.
- Пищулин А.А., Карпова Е. А. Овариальная гиперандрогения и метаболический синдром Русский медицинский журнал 2001- 9: с. 9397.
- Романцова Т.И. Актуальные проблемы нейроэндокринологии. М. 2003. С.59−65
- Семенов Б.Ф., Варгин В. В. Иммуномодуляция при вирусных инфекциях и вакцинации. М., ВИНТИ, 1989.
- Семенов Б.Ф., Покровский В. И. Вакцинопрофилактика инфаркта, инсульта и летальности при эпидемическом подъеме гриппа. Журнал микробиологии-, эпидемиологии и иммунобиологии. 2004. — № 2. — С. 95−99.
- Семенов Б.Ф., Покровский В. И. Вакцинопрофилактика инфаркта, инсульта и летальности при эпидемическом подъеме гриппа. Журнал микробиологии, эпидемиологии и иммунобиологии. 2004. — № 2. — С. 95−99.
- Терапевтический архив. 2004. — № 10. — с. 58−62.
- Сусеков А.В. Пути коррекции уровня липидов при лечении больных с метаболическим синдромом и сахарным диабетом 2 типа. Сердце. л2005- т.4, № 5. — с.259−261.
- Титов В.Н. Метаболический синдром, физико-химические и биологические основы патогенеза, формирования симптомов, диагностики и лечения. Клиническая лабораторная диагностика. — 2005. № 9. — С. 10.
- Филиппов А.Е. Влияние инфекционного и воспалительного факторов на неблагоприятные исходы ишемической болезни сердца. Автореферат дис. Канд.мед.наук. СПб., 2002. — 39 с.
- Хаитов М.Р., Острые респираторные вирусные инфекции и бронхиальная астма. Клеточные и молекулярные аспекты проблемы. Журнал микробиологии, эпидемиологии и иммунобиологии. — 2002. -№ 4. С. 84−93
- Цаллагова Е.В., Прилепская В. Н. Роль снижения избыточной массы тела в восстановлении функции репродуктивной системы женщин. Гинекология. 2001. № 1. — с. 1−3.
- Чазова Е.И., Мычка В. Б. Метаболический синдром: подходы к лечению. Consilium provisorum. — 2003. № 8. — С.2−3.
- Чазова И.Е., Мычка В. Б. Основные принципы диагностики и лечения метаболического синдрома. Сердце. — 2005. т.4, № 5. — С. 232−235.
- Чучалин А. Г., Синопальников А. И., Чернеховская Н. Е. Пневмония.
- М.:Экономика и информатика, 2002. 376 с.
- Чучалин А.Г., Синопальников А. И., Яковлев СВ., Страчунский Л.С,
- Козлов Р. С, Рачина С. А. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике.
- Пособие для врачей. Смоленск, 2003. 68 с. 74. Шахнович П. Г., Филиппов А. Е., Лобзин Ю. В., Бойцов С. А, Линчак
- P.M. Связь внутриклеточных инфекций с функцией эндотелия ифакторами сердечно-сосудистого риска у больных артериальнойгипертензией // Вестник Российской военно-медицинской академии. —2005.-№ 2(13).-С. 140−145.
- Шевченко О.П. Клиническое значение количественного анализа Среактивного белка // Лаборатория. 1997. — № 7. — С. 7−8.
- Шевченко Ю.Л. Роль современных факторов во взаимодействии человека и микроорганизмов. Значение национального здравоохранения в профилактике и лечении инфекционных болезней // Журнал микробиология, эпидемиология и иммунобиология. — 2000. № 6. С. 3-ч6.
- Эпидемиология иммунодефицитов. // ВНИИМИ. М. — 1988. — С. 24−53.
- Яковлев М.Ю. Элементы эндотоксиновой теории физиологии и патологии человека. Физиология человека 2003- Т. 29, 3: С. 94.
- Ярилин А.А. Апоптоз и его место в иммунных процессах. Иммунология 1996- 6: с. 10−23.- 12 680. Abraham S., Jonsson A. Fimbriaemediated host-pathogen cross-talk.
- Curr. Opin. Microbiol. 1998- 1: 75—81.
- Aguirre V. et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 2002- 277:1531−1537.
- Aguirre V. et al. The c-Jun NH (2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307). J. Biol. Chem. 2000- 275: 9047−9054.
- Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell В., Maratos-Flier E., Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature 1996- 382: 250−252.
- American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention // Am. J. Respir. Crit. Care. Med. -2001. Vol.163.-P. 1730−1754.
- Aoun ML, Klastersky J. Drug treatment of pneumonia in the hospital // Drugs,-1991.-Vol. 42, № 2, — P. 962−973.
- Arnold F.W., Ramirez J.A., McDonald L.C., Xia E.L. Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment//Chest.-2003.-Vol. 124, № l.-P. 121−124.
- Bahtiyar G. et al. Association of diabetes and hepatitis С infection: epidemiologic evidence and pathophysiologic insights. Curr. Diab. Rep. 2004- 4: 194−198.
- Barbier О., Torra I.P., Duguay Y. et al. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis // Arterioscler. Thromb. Vase. Biol. 2002. — Vol. 22. — P. 717−722.
- Barbier O., Torra I.P., Duguay Y. et al. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis // Arterioscler. Thromb. Vase. Biol. 2002. — Vol. 22. — P. 717−722.
- Bardin P.O., Sanderson G., Robinson B.S. et al. Experimental rhinovirus infection in volunteers. Eur. Respir. J. 1996, 9: 2250 2255.
- Bartlett J.G., Breiman R.F., Mandell LA, File T. M.Jr. Community-acquired pneumonia in adults: guidelines for management // Clin. Infect. Dis.- 1998.- Vol.26.-P. 811−838.
- Bartlett J.G., Dowell S.F., Mandell LA, File T.M., Musher D.M., Fine M.J. Practice guidelines for the management of community-acquired pneumonia in adults // Clin. Infect. Dis.- 2000.-Vol. 31.- P. 347−382.
- Bassler B. How bacteria talk to each other: regulation of gene expression by quorum sensing. Curr. Opin. Microbiol. 1999- 2: 582−587.
- Beck-Nielsen H. General characteristics of the insulin resistance syndrome: prevalence and heritability European Group for the study of Insulin Resistance (EGIR). Drugs 1999- 58: 5−7.
- Benditt E. P., Benditt J. M. Evidence for monoclonal origin of atherosclerosis // Proc. Natl. Acad. Sci. USA. 1973. Vol. 70. P. 1753−1756.
- Benson S.C. et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension. 2004. 43(5). — P. 993−1002.
- Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 2002- 13: 84−89.
- Biasucci L. M., Liuzzo G., Grillo R. L. et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability // Circulation. 1999. Vol. 99. P. 855−860.
- Bjorntorp P., Holm J., Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diab. Med. 1999- 16: 373−383.
- Blondeau J.M. The evolution and role of macrolides in infectious diseases// Expert. Opin. Pharmacother.- 2002.- Vol. 3, № 8.- P. 1131−1151.
- Boden G. Role of fatty acid in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997- 46: 3−10.
- Bonora E., Kiechl S., Willeit J. et al. Prevalence of insulin resistance in metabolic disorders. The Bruneck study. Diabetes 1998- 47: 1643 1649.
- Bouloumie A. et al. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001- 50: 2080−2086.
- Brent E. W. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J. Am. Soc. Nephrol. 2004- 15:2792−2800.
- Bressler B.L., Guindi M., Tomlinson G., Heathcote J. High index of weight of a body an independent risk factor of an inefficiency of anti-virus treatment at a chronic hepatites C. Hepatology. 2003. 28(3): 293−302.
- British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults // Thorax.- 2001.- Vol. 56 (Suppl 4).- P. 1−64.
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001- 414: 813−820.
- Buffon A., Liuzzo G., Biasucci L. M. et al. Pre-procedural serum levels of C-reactive protein predict early complications and late restenosis aftercoronaiy angioplasty // J. Am. Coll. Cardiol. 1999. Vol. 34. P. 1512−1521.
- Canturk Z., Canturk N.Z., Cetinarslan В., Utkan N.Z., Tarkun I.. IntrahoSpital infections and adiposity at surgical patients. — Obes. Res. 2003. 11(6): 769−775.
- CDC. Outbreak of group A streptococcal pneumonia among Marine Corps recruits California, November 1-December 20, 2002. // Morb. Mortal. Wkly. Rep.- 2003.- Vol. 52, № 6.- P. 106−109.
- Centers for disease control and prevention and control of influenza. MMWR. 2003,52: 1 —36
- Chae C. U., Lee R. Т., Rifai N. et al. Blood pressure and inflammation in apparently healthy men // Hypertension. 2001. Vol. 38. P. 399−403.
- Chandra R.K. Cell-mediated immunity in genetically obese. Am. J. Clin. Nutr. 1980- 33:13−16.
- Chandron M., Phillips S.A., Ciaraidi Т., Henry R.R. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003- 26: 2442−2450.
- Charriere G. et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 2003- 278: 9850−9855.
- Charriere G., Cousin В., Arnaud E., Andre M., Bacou F., Penicaud L., Casteilla L. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol. Chem. 2003- 278: 9850−9855.
- Program with abstreact on disk.-Abstract PI016.
- Coley СМ., Li Y.H., Medsger A.R., et al. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia // Arch. Intern. Med.-1996.-Yol. 156, № 14.- P. 1565−1571.
- Cook P.J., Lip G.Y.H., Davieset P., et al. Chlamydia pneumoniae Antibodies in Severe Essential Hypertension // Hypertension. 1998. — Vol. 31(2). — P.589−594.
- Cottam D.R., Schaefer P.A., Shaftan G.W., Angus L.D. Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery. Obes Surg. 2003- 13(l):49−57
- Cousin В., Munoz O., Andre M., Fontanilles A.M., Dani C., Cousin J.L., Laharrague P, Casteilla L, Penicaud L. A role for preadipocytes as macrophage-like cells. FASEB J. 1999−13: 305−312.
- Culora G. A., Moore I. E. Kawasaki disease, Epstein-Ban' virus and coronary artery aneurysms. J. Clin. Pathol. 1997- 50 (2): 161−163.
- Cunningham M.J., Clifton D.K., Steiner R.A.: Leptin’s actions on the reproductive axis: perspectives and mechanisms. Biol. Reprod. 1999- 60: 216−222.
- Dagan R., Klugman K.P., Craig W.A., Baquero F. Evidence to support thera tionale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy // J. Antimicrob. Chemother.-2001.-Vol. 47.-P. 129- 140.
- Dandona P., Aljada A., and Bandyopadhyay, A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends. Immunol. 2004- 25: 4−7.
- Dandona P., Aljada A., Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends. Immunol. 2004- 25: 4−7.
- Dandona P., Aljada A., Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004- 25: 4−7
- Dandona P., Aljada A., Chaudhuri A., Mohanty P. Metabolic Syndrome Circulation, 2005−111:1448−1454.
- Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic Syndrome Circulation. 2005−111:1448−1454.
- Dandona P., Aljada A., Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002- 45: 924−930.
- Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease? is there a link? Lancet 1997:350:430−436.
- Di Napoli M., Papa K, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor// Stroke. 2001. Vol. 32. P. 917−924.
- El-Solh A.A., Sikka P., Ramadan F., Davies J. Etiology of severepneumonia in the very elderly // Am. J. Respir. Crit. Care. Med.- 2001.41. Vol. 163, № 3,-P. 645−651.
- Epstein M., Brunner H.R., eds. Angiotensin II Receptor Antagonists. 1st ed. Philadelphia. Pa: Hanleyand Belfus- 2001.
- ESH-ESC Guidelines Committee. ESH-ESC guidelines for the management of arterial hypertension. J Hypertens 2003- 21: 1011—1053.
- Espinola-Klein C., Rupprecht H.J., Blanken-berg S. et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis // Circulation. 2002. Vol. 105. P. 15−21.
- Espiiiola-Klein C., Rupprecht H. J., Blankenberg S. et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002- 105: 2—4.
- Esposito K., Nicoletti G., Giugliano D. Obesity, cytokines and endothelial dysfunction: a link for the raised cardiovascular risk associated with visceral obesity Л.Endocrinol. Invest. 2002- 25: 646−649.
- Esposito S., Blasi F., Bellini F., Allegra L, Principi N. Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgii Study Group//Eur. Respir. J.-2001.-Vol. 17, № 2.-P. 241−245.
- Evans J.L., Goldfme I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Rev. 2002- 23, 599−622.
- Everard M.L., Swarbrick A., Wrightham M. et al. Analysis of cells obtained by bronchial lav-age of infants with respiratory syncytial virus infection. Arch. Dis. Child. 1994, 71: 428 -432.
- Ewig S. Community-acquired pneumonia: epidemiology, risk, and prognosis
- Fabricant C. G., Fabrican J., Litrenta M. M. et al. Virus-induced atherosclerosis // J. Exp. Med. 1978. Vol. 148. P. 335−340.
- Falguera M., Sacristan 0., Nogues A., et al. Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity // Arch. Intern. Med.- 2001. -Vol. 161, № 15.-P. 1866−1872.
- Fang G.-D., Fine M., Orloff J. New and emerging etiologies for community- acquired pneumonia with implications for therapy // Medicine.- 1990.- Vol. 69.P. 307−316.
- Farooqi I.S. et al. Beneficial effects of leptin on obesity, T- cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 2002- 110: 1093−1103.
- Feingold K.R., Grunfeld C., Pang M. et al. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes mellitus // rterio-scler. Thromb. 1992. — Vol. 12. — P. 1496−1502.
- Fernandes G. et al. Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. I. Clin. Invest. 1978- 61: 243−250.
- Ferwerda A., Moll H.A., Hop W.C.J., et al. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections // J. Antimicrob. Chemother.- 2001.- Vol.
- Festa A., D’Agostino R. Jr., Howard G., Mykkanen L., Tracy R.P., Haffher S.M.: Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102: 42−47.
- Festa A., D’Agostino R. Jr., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000- 102: 42−47.
- Finch R.G., Woodhead M.A. Practical considerations and guidelines for the management of community-acquired pneumonia // Drugs.- 1998.-Vol. 55.-P. 31−45.
- Fine J.M. Aetiology and incidence of community-acquired pneumonia // Infect Dis. Clin. Pract.-1996.-Vol. 5 (Suppl. 4).- P. 127−135.
- Fine: M. J., Auble Т. E., Yealy D. M., et al. A prediction rule to identify low-risk patient with community-acquired pneumonia // N. Engl. J. Med.- 1997.- Vol. 336.- P. 243−350.
- Fine M.J., Hough L.J., Medsger A.R., et al. The hospital admission decision for patients with community-acquired pneumonia. Results fromthe pneumonia patient outcomes research treatment cohort study // Arch. Intern. Med.- 1997.- Vol. 157.-P. 36. ,
- Fine M.J., Smith D.N., Singer D.E. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study // Am. J. Med.- I990.-Vol. 89.-P. 713.
- Folkbrts G., Verheyen A., Janssen M., Nijkamp P.P. Virus-induced airway hyperresponsiveness in the guinea pig can be transferred by bron-choalveolar cells. J. Allergy Clin. Immunol. 1992,90:364−372.
- Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among ,-US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002- 287: 356−359.
- Frothingham C. The relationship between acute infectious diseases and arterial lesions // Arch. Intern. Med. 1911. Vol. 8. P. 153−162.
- Fukuhara A. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005- 307: 426−430.
- Furukawa S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest 2004- 114:1752−1761.
- Gao Z. et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol. Endocrinol. 2004- 18 :2024−2034.
- Gern J.E., Busse W.W. Association of rhinovirus infections with asthma. Clin. Microbiol. Rev. 1999, Jan: 9- 18.
- Gern J.E., Dick E.G., Lee W.M. et al. Rhino-virus enters but does not replicate inside mono-cytes and airway macrophages. J. Immunol. 1996, 156:621−627.
- Gleason P.P. The emerging role of atypical pathogens in community- acquired pneumonia // Pharmacotherapy.- 2002.- Vol. 22 (Suppl.M, Pt.2).-P. 2S-11S.
- Grimble R.F. Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2002- 5, 551−559.
- Grunberg K., Timmers M.C., Smits H.H. et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin. Exp. Allergy'. 1997, 27: 36−45.
- Grunfeld C., Zhao C., Fuller J., Pollack A., Moser A., Friedman J., Feingold K.R. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 1996- 97: 2152−2157.
- Guil.lemot D., Carbon C, Balkau В., Greslin P., Lecoeur H., Vauzelle- Kervroedran F. Low dosage and long treatment duration of beta-lactam: risk factors for carnage of penicillin-resistant Streptococcus pneumoniae //JAMA.-1998.-Vol. 279.- P. 365−370.
- Guillevin L., Lhote F., Gherardi R. The spectrum and treatment of virus-associated vasculitides // Curr. Opin. Rheumatol. 1997. Vol. 9. P. 31−36.
- Gupta S., Leatham E. W., Carrington D. et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction // Circulation. 1997. Vol. 96. P. 404−407.
- Gupta S., Leatham E. W., Carrington D. et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997- 96: 404−407.
- Gupta S.K., Sarosi G.A. The role of atypical pathogens in community-acquired pneumonia // Med. Clin. North. Am.- 2001.- Vol. 85, № 6.- P. 1349−1365, vii.
- Gurfmkel E., Bozovich G., Beck E. et al. Treatment with the antibiotic roxitromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. Eur. Heart. J. 1999- 20: 121−127.
- Gurfinkel E., Bozovich G., Beck E. et al. Treatment with the antibiotic roxithromycin in patients with non-Q-wave coronariy syndromes. The final report of the ROXIS study. Eur Heart J 1999:20:121−129.
- Gwfinkel E., Bozovich G., Beck E. et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study // Eur. Heart J. 1999. Vol. 20. P. 121−127.
- Hansson G.K., Stemme S, Paulsson G. Et al. Autoimmunity in atherosclerosis // Atherosclerosis XI / Eds. B. Jacotot, D. Mathe, J.-C. Fruchart. Singapore: Elsevier Scien., 1998. — P. 979−983.
- Hardardottir I., Grunfeld C., Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism // Cuir. Opin. Lipidology. 1994. — Vol.5. — P. 207−215.
- Hatada E.N., Krappmann D., Scheidereit C. NF-kappaB and the innate immune response. Curr. Opin. Immunol. 2000- 12: 52−58.
- Hauner H., Bender M., Haastert В., Hube F. Plasma concentration TNFa and its soluble receptors in obese subjects. Int. J. Obes. Relat. Metab. Disord. 1998−22: 1239−1243.
- Henry R. Preventing cardiovascular complications of type 2 diabetes: focus on lipid management. Clinical Diabetes. 2001. 19(3): 743−759.
- Hentschel U., Hacker J. Pathogenicity islands: the tip of the iceberg. Microb. Infect. 2001- 3: 545—548.
- Hirosumi J. et al. A central role for JNK in obesity and insulin resistance.
- Nature. 2002- 420: 333−336.
- Hoeffken G., Meyer H.P., Winter J., Verhoef L. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia // Respir. Med.-2001- Vol. 95, № 7.- p. 553−564.
- Hotamisligil G.S., Arner P., Caro J.F. et al. Increased adipose tissue expression of tumour necrosis factor-a in human obesity and insulin resistance // J. Clin. Invest. 1995. — Vol. 95. — P. 2409−2415.
- Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993- 259: 87−91.
- Howard J.K., Lord G.M., Matarese G., Vendetti S., Ghatei M.A., Ritter M.A., Lechler R.I., Bloom S.R. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 1999−104: 1051−1059.
- Hoyert D.L., Kochanek K.D., Murphy S.L. Deaths: final data for 1997 // Natl.Vital. Stat. Rep.-1999- Vol. 47.- P. 1−105.
- Hsue P., Waters D. What a cardiologist needs to know about patients with human immunodeficiency virus infection //Circulation, December 20/27, 2005- 112: 3947−3957.
- Hsueh W.A. Law R. The central role offal and effect of peroxisome proliferator-aeiivatcd receptor-y on progression of insulin resistance and cardiovascular disease. Am. J. Cardiol. 2003- 92:3.1−9.
- Isenberg H. Pathogenicity and virulence: another view. Clin. Microbiol. 1988- 1:40—53.
- Ishizaka N., Ishizaka Y., Takahashi E. et al. Increased prevalence of carotid atherosclerosis in hepatitis В vims carriers // Circulation. 2002. Vol. 105. P. 1028−1030.
- Jeschke M.G., Klein D., Bolder U., Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology. 2004- 145: 4084−4093
- Johnston S.L. Viruses and asthma. Allergy. 1998, 53: 922 932.
- Jovinge S., Hultgardh A., Regnstrom J., Nilsson J. Tumor necrosis factor-a activates smooth muscle cell migration in culture and Is expressed in the balloon-injured rat aorta // Arterioscler. Thromb. Vase. Biol. 1997. — Vol. 17.-P. 490−497.
- Juvonen J. Demonstraition of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. // J. Vase. Surg. — 1997. Vol. 25. — P. 499 505.
- Kaftan H. A., Kaftan O., Kilic M. Markers of chronic infection and inflammation. Are they important in cases with chronic coronary heart disease. Jpn Heart J. 1999- 40 (3): P 275—279.
- Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005. 28: 2289−2304
- Kahn R., Buse J., Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association the
- European Association for the Study of Diabetes. Diabetes Care 2005- 28: 2289−2304.
- KatritsisD., Kowvesis S., Giazitoglou E. etal. C-reactive protein concentrations and angiographic characteristics of coronary lesions // Clin Chem. 2001. Vol. 47. P. 882−886.
- Keller D. W., Breiman R. F. Preventing bacterial respiratory tract infectionsamong persons infected with human immunodeficiency virus // Ciin. Infect. Dis.1995.-Vol. 21 (Suppl. 1).- P. S77-S83.
- Khovidhunkit. W. et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host review. J. Lipid Res. 2004- 45:1169−1196.
- Kiechl S., Egger G., Mayr M. et al. Chronic infections and the risk of carotid atherosclerosis // Circulation. 2001. Vol. 103. P. 1064−1070.
- Klein B.E., Klein R., Lee K.E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002- 25: 1790−1794.
- Knobler H. et al. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis С virus-diabetes association. Am. J. Gastroenterol. 2003−98:2751−2756.
- Komarakshi R., Kuruvilla S. Role of inflammation in atherosclerosis: immunohistochemical and electron microscopic images of a coronary indarterectomy specimen //Circulation, Jan 2006- 113:41 43.
- LaBiche R., Koziol D., Quinn T. et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque // Stroke. 2001. Vol. 32. P. 855−860.
- Laurichesse H., Robin F., Gerbaud L, et al. Empirical therapy for nonhospitalized patients with community-acquired pneumonia // Eur. Respir. J.- 1998.- Vol. 11, № l.-P. 73−78.
- Laurichesse H., Sotto A., Bonnet E., et al. Pre- and in-hospital management of community-acquired pneumonia in Southern France, 199 899 // Eur. J. Clin.Microbiol. Infect. Dis.- 2001.-Vol. 20.- P. 770−778.
- Laurila A., Bloigu A., Nayha S. et al. Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. Br Med J 1997:314:1456−1457.
- Lehrke M. et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004- 104: 1371.
- Leinonen M., Saikku P. Infections and atherosclerosis. Scand. Cardiovasc. J. 2000- 34 (1): 12−20.
- Leophonte P. Can aminopenicillin be prescribed as monotherapy in case of community-acquired pneumonia? // Presse. Med.- 1998.- Vol. 27, № 31.- P.1580−1581.
- Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis // Circulation. — 1997. Vol. 96. — P. 40 954 103.
- Lord G. Role of leptin in immunology. Nutr. Rev. 2002−60: 35−38.
- Lord G.M. et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998- 394: 897 901.
- Luna СМ., Famiglietti A., Absi R., et al. Community-acquired pneumonia.
- Etiology, epidemiology, and outcome at a teaching hospital in Argentina //Chest.- 2000.-Vol. 118, № 5.- P. 1344−1354.
- Lyon C. J" Law R.E., Hsueh W.A. Adiposity, inflammation, and atherogenesis Endocrinology 2003- 144: 2195−2200.
- Maass M., Bartels C., Kruger S. Et al. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998- 140: Suppl I: S25-S30.
- MacFarlane J.T. DM thesis // Oxford University.-1982.- P. 323.
- Makowski, L. et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoproteinE against atherosclerosis. Nat. Med. 2001- 7: 699−705.
- Mandell L. A. Guidelines for community-acquired pneumonia: a tale of 2 countries // Clin. Infect. Dis.- 2000.- Vol. 31- P. 422−425.
- Martie Т. J., Peeling R. W., Fine M. J., et al. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course //Am. J. Med.-1996.-Vol. 101.- P. 508−515.
- Marston B. J., Lipman H.B., Breiman R.S. Surveillance for legionnareire’sdisease: risk factors for morbidity and mortality // Arch. Intern. Med.- 1994.-Vol. 154.-P. 241−244.
- Marti A., Marcos A., Martinez J.A. Ожирение и функция иммунной системы. Obesity Rev. 2001- 2: 131.
- Mason A., Wick M., White H. et al. Hepatitis В virus replication in diverse cell types during chronic hepatitis В virus infection // Hepatology. 1993. Vol. 18. P. 781−789.
- Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001- 1: 135−145.
- Meigs J.B., D’Agostino R.B. Sr., Wilson P.W., Cupples L.A., Nathan D.M., Singer D.E. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997- 46: 15 941 600. ч
- Melbye H., Berdal B. P., Straume В., Russell H., Vorland L, Thacker W.L. Pneumonia a clinical or radiographic diagnosis // Scand. J. Infect. Dis.- 1992.-Vol. 24.- P. 647−655.
- Melissano G., Blast F., Esposito G. et al. Chlamydia pneumoniae eradication from carotid plaques: results of an open, randomized treatment study // Eur. J. Vase. Endovasc. Surg. 1999. Vol. 18. P. 355−359.
- Microbial treats to health. M.S. Smolinslci, M.A. Hamburg, J. Lederberg (ed.) National Academies press, Washington, 2003.
- Miettinen H., Lehto S., Saikku P. Et al. Association of Chlamydia pneumonia and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996:17:682−688.
- Miller C. et al. Tumor necrosis factor-alpha levels in adipose tissue of lean and obese cats. J. Nutr. 1998- 128(Suppl.l2): 2751−2752.
- Minogue M.F., Coley СМ., Fine M.J., Marrie T.J., Kapoor W.N., Singer D.E. Patients hospitalized after initial outpatient treatment for community-acquired pneumonia // Ann. Emerg. Med.-1998.- Vol. 31, № 3.- P. 376 380.
- Miyazaki Y., Pipek R., Mandarino L.J.. The factor tumor necrosis-a and insulin resistance at adiposity combined with CD 2 types. Int. J. of Obes. 2003.27: 88−94.
- Monsieur I., Meysman M., Vincken W., et al. Severe community-acquired pneumonia caused by atypical organisms //Acta. Clin. Belg.-1997.- Vol. 52.- P. 112−115.
- Muhleslein J. В., Anderson J. L., Cartquist J. F. et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study // Circulation. 2000. Vol. 102. P. 1755−1760.
- Murphy S.L. Deaths: final data for 1998 // Natl. Vital. Stat. Rep.-2000.- Vol. 48.-P. 1−106.-145 263. Nakatani Y. et al. Involvement of endoplasmic reticulum stress in insulinresistance and diabetes J. Biol. Chem. 2005- 280: 847−851.
- Neels J.G., Olefsky J.M. Inflamed fat: what starts the fire? J. Clin. Invest. 2006- 146: 33−35.
- Neumann F. J. Chlamydia pneumoniae — atherosclerosis link // Circulation. 2002. Vol. 106. P. 2414−2416.
- Nichol K.L., Nordin J., Mulooly et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J.Med. 2003, 14: 1322−1332.
- Nichol K.L., Nordin J., Mulooly et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl.J.Med. 2003, 14: 1322−1332.
- Nieman D.C., Nehlsen-Cannarella S.L., Henson D.A., Koch A.J., Butterworth D.E., Fagoaga O.R., Warren B.J., Rainwater M.K. The immune answer to adiposity and the moderate loss of weight. Obes. Metab. Disord. 1996. 20(4): 353−360.
- Chlamydia pneumoniae infection with high blood pressure in Japanese adults
- American Journal of Hypertension. 2001. — Vol. 14(1). — P. 20−26.
- Noah T.L., Henderson F.W., Wortman I.A. et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J. Infect. Dis. 1995, 171:584−592.
- NtsekheM., HakimJ. Impact of human immunodeficiency virus infection on cardiovascular disease in africa//Circulation, Dec 2005- 112: 3602 3607.
- Ouchi N. et al. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003- 14: 561−566.
- Ouchi N., Kihara S., Arita Y. et al Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway Circulation 2000- 102,1296−1301.
- Ozawa K. et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 2005- 54: 657−663.
- Ozcan U. et al. Endoplasmic reticulum stress links obesity, insulin action, and typfe 2 diabetes. Science 2004- 306: 457−461.
- Papanicolaou D. Interleukin-6: the endocrine cytokine. J. Clin. Endocrinol. Metab. 2000- 85: 1331−1333.
- Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004- 27: 813−823.
- Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998- 41: 1241−1248.- 147 283. Pitiriga V.C., Kotsis V.T., Papamichail C.M. et al. High prevalens of
- Chlamydia pneumoniae antibodies in white-coat hypertensives //
- Atherosclerosis. 2003. — Vol. 167 (2). — P. 231−235.
- Plata-Salaman C.R. Anorexia during acute and chronic disease. Nutrition 1996- 12: 69−78.
- Pomilla P.V., Brown R.B. Outpatient treatment of community-acquired pneumonia in adults//Arch. Intern. Med.-1994, — Vol. 154.- P. 1793.
- Porath A., Schlaeffer F., Lieberman D. The epidemiology of communityacquired pneumonia among hospitalized patients // J. Infect.-1997.- Vol. 34.- P. 41−48.
- Porath A., Schlaeffer F., Pick N., Leinonen M., Lieberman D. Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients // Eur. J. Clin. Microbiol. Infect. Dis.-1997.-Vol. 16, № 12.- P. 863 870.
- Prager M., Turel Z, Speidl W. et al. Chlamydia pneumoniae in carotid artery atherosclerosis. A comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals // Stroke. 2002.10.1161.
- Prasad A., Zhu J., Halcox J. et al. Predisposition to atherosclerosis by infections // Circulation. 2002. Vol. 106. P. 184−190.
- Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy- September 17−20, 2000, Toronto, Ontario, Canada.-Abstract 1381.
- Proud D., Naclerio R.M., Gwaltney J.M., Hendley J.O. Kinins are generated in nasal secretions during natural rhinovirus colds. J. Infect. Dis. 1990, 161: 120- 123.
- Rader D.J. Inflammatory markers of coronary risk. N. Engl. J. Med. 2000- 343:1179−1182.- 148 293. Rajala M.W., Scherer P.E.The adipocyte at the crossroads of energyhomeostasis, inflammation, and atherosclerosis. Endocrinology 2003- 144:3765−3773.
- Rana, J.S. et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004- 27: 2478−2484.
- Rask E., Olson Т., Soderberg S. Tissue-specific dysregulation of Cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 2001- 86:14 181 421.
- Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988- 37: 1595−1607.
- Reynolds R.M., Walker B.R. Human insulin resistance: the role of glucocorticoids, Diab. Obes. Metab. 2003- 5: 5−12.
- Rhew D. Overview of recent guidelines for the management of community acquired pneumonia // JCOM.- 2002.- Vol. 9, № 7.- P. 381−388.
- Ridker P.M. High-sensitivy C-reactive protein: potencial adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation2001- Vol. 103.-P. 1813−1818.
- Ridker P.M., Rifai N., Rose L. et al. Comparison of C-reactiv protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 2002- Vol. 347. P. 1557−1565.
- Rizzo S. Mycoplasma pneumoniae pulmonitis: delayed diagnosis and empirical therapy // Minerva. Med.-1998.- Vol. 89, № 4.- P. 99−103.
- Rosenson R.S., Reasner C.A. Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes. Curr Opin Cardiol 2004- 19: 480−487.
- Ruiz A., Falguera M., Sacristan O., et al. Community-acquired pneumonia: usefulness of clinical presentation in the selection of antibiotic treatment // Med.Clin.- 2002.- Vol. 119, № 17.- P. 641−643.
- Rupprecht H.J., Blankenberg S., Bickel C. et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease // Circulation. 2001. Vol. 104. P. 25−31.
- Saikku P., Leinonen M., Mattila K. et al. Serologic evidence of an association of a novel Chlamydia, TWAR. with chronic coronary heart disease and acute myocardial infarction. Lancet 1988:289:983−985.
- Salktnd A.R., Cuddy P.G., Foxworth J.W. Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis // Ann. Pharmacother.-2002.- Vol. 36.-P. 1938−1943.
- Saltiel A.R., Pessin J.E. Insulin signaling pathways in time and space. Trends, Cell. Biol. 2002- 12: 65−71.
- Sander D., Schulze-Horn C., Bickel H., Gnahn H., Bartels E., Conrad B. Combined effects of hemoglobin Ale and C-reactive protein on the progression of Subclinical carotid atherosclerosis: the invade study // Stroke. -2006.-33 (2).- P. 351.
- Sander D., Winbeck K., Klingelhofer J. et al. Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity// Circulation. 2001. Vol. 103. P. 1390−1395.
- Schillinger M., Exner M., Mlekusch W., Sabeti S., Amighi J., Nikowitsch R., Timmel E., Kickinger B. Et al. Inflammation and carotid artery — risk for atherosclerosis study (ICARAS) // Circulation. 2005. — 111. — P. 22 032 209.
- Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000−404: 661−671.
- Sehiffrin L.L., Ainiri F., Benkirane K., Iglarz M., Dicp Q.N. Peroxisome prolileraior-activaled receptors: vascular and cardiac effects in hypertension. Hypertension. 2003- 42: 664—668.
- Shor A., Kuo С. C., Patten D. L. et al. Detection of Chlamydia Pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 1992- 82: 158−161.
- Simonsen L. The global impact of influenza on morbidity and mortality, accine. 1999,17 (suppl.): 3—10.
- Sinisalo J., Mattila K., Valtonen V. et al. Effect of 3 months antimicrobial treatment with Clarithromycin in acute non-Q-wave coronary syndrome // Circulation. 2002. Vol. 105. P. 1555−1560.
- Sonnenberg G.E., Krakower G.R., Kissebah A.H. A novel pathway to the manifestations of metabolic syndrome obesity research 2004−12: 180−186.
- Sorensen T.I., Echwald S., Holm J.C. Leptin in obesity. Br. Med. J. 1996- 313:953−954.
- Soukas A. et al. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 2000- 14: 963−980.
- Stentz F.B., Umpierrez G.E., Cuervo R., Kitabchi A.E. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004- 53: 2079−2086
- Steppan C.M., Lazar M.A. The current biology of resistin. J. Intern. Med.2004- 255: 439−447.
- Stone A., Mendall M., Kaski J.-C. et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes // Circulation. 2002. Vol. 106. P. 1219−1223.
- Sumida Y., Nakashima Т., Yoh T. et al. Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases // Liver. 2001. Vol. 21. P. 295−299.
- Tedgui A., Mallat Z. Anti-inflammatory mechanisms in the vascular wall // Circulation Res. 2001. — Vol. 88. -P. 877−889.
- Thom D.H., Wang S.P., Grayston J.T. et al. Chlamydia pneumoniae strain TWAR’antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991:11:547—551
- Thorburn C.E., Knott S.J., Edwards D.I. In vitro activities of oral beta-lactamsat concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance // Antimicrob. ч 152 1. Agents.
- Chemother.-1998.-Vol. 42, № 8.- P. 1973−1979.
- Tontonoz P. et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998- 93: 241−252.
- Tsigos C., Papanicolaou D.A., Kyrou I. et al. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation // J. Clin. Endocrinol. Metab. 1997. — Vol. 82. — P. 4167−4170.
- UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure contraband risk of macrovascular and microvascular complications in type 2 diabetes. Br Med J 1998- 317: 705−713.
- Unger R.H. Lipotoxic Diseases. Annu Rev. Med. 2002- 53: 319−336.
- Unger R.H., Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 2001- 15: 312−321.
- Vanhala M.G., Pitkajarvi Т.К., Kumpusalo E.J., Takala J.K. Metabolic syndrome in middle-aged Finnish population. J Cardiovasc. Risk 1997- 4: 291−295.
- Ward M.E. The immunobiology and immtinopathology ot chlamydial infections. APMIS 1995:103:769−796.
- Weisberg S.P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003- 112:1796−1808.
- Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes J. Clin. Invest. 2005−115:1111−1119.
- Wiesli P., Czerwenka W., Meniconi A. et al. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men// Circulation. 2002. Vol. 105. P. 2646−2652.
- Wiesli P., Czerwenka W., Meniconi A. et al. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men // Circulation. 2002. Vol. 105. P. 2646−2652.
- Wipf J.E., Lipsky В. A., Hirschmann J.V., et al. Diagnosing Pneumonia by Physical Examination Relevant or Relic? //Arch. Intern. Med.-1999.- Vol. 159.-P. 1082−1087.
- Woodhead M.A. Studies on pneumonia in the community and in hospital in Nottingham. DM thesis, University of Nottingham 1988.
- World health Report 2002: Reducing risks, promoting healthy life. Geneva, 2002.
- Xu H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003- 112: 1821−1830.
- Yu C. et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-l)-associated phosphatidylinositol 3-kinase activity. in muscle J. Biol. Chem. 2002- 277: 50 230−50 236.
- Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994- 372: 425132.
- Cardiol. 2000- 85 (2): 140—146.
- Zick Y. Role of Ser/Thr kinases in the uncoupling of insulin signaling. Int. J. Obes. Relat. Metab. Disord. 2003- 27, 3: 56−60.
- Hodge A.M., Воуко E.J., Courten M. et al. Leptin and other components of the metabolic syndrome in mauritius-a factor analysis. J. Obes. Relat. Metab. bisord. 2001- 25: 126−131.